IPO filing research

ADARx Pharmaceuticals, Inc.

Pharmaceutical Preparations · ADRX

ipo amended Nasdaq Global Market S-1

ADARx Pharmaceuticals, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-09-04. Current deal snapshot: exchange Nasdaq Global Market.

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

Common · Exchange Nasdaq Global Market · Ticker ADRX · Use of proceeds To advance development of therapeutic candidates, including clinical trials, and for working capital · Underwriters J.P. Morgan Securities LLC

ADARx Pharmaceuticals, Inc. is conducting an IPO with an S-1 filing dated 2026-09-04, replacing a previous DRS/A filing. The offering includes 88,250,216 shares of common stock outstanding as of June 30, 2026, after converting convertible preferred stock into 76,920,354 shares. The filing outlines reserved shares for equity plans (2026 Plan and ESPP) and excludes unexercised options. Pro forma financials show significant net losses, with $48.4 million in six months ended June 30, 2026, and an accumulated deficit of $269.1 million as of that date.

2026-09-04 · 0001193125-26-383838

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2026-07-31 · 0001193125-26-328843

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

2026-06-22 · 0001193125-26-277710

Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 20 using nearest neighbors.

Showing top 8 by similarity.

+9.1%

Median day-1

60%

Above issue

+10.6%

Median week-1

-16.7%

Downside (p10)

Vogenx, Inc. VOGX

2026-08-12 $81M Day 1: +0.0% Wk 1: +51.9%

same SICrecent IPO

BlossomHill Therapeutics, Inc. BLSM

2026-08-07 $150M Day 1: +0.0% Wk 1: +2.2%

same SICrecent IPO

Latigo Biotherapeutics, Inc. LTGO

2026-08-07 $346M Day 1: +1.4% Wk 1: +11.4%

same SICrecent IPO

Braveheart Bio, Inc. BRVE

2026-08-06 $383M Day 1: +65.6% Wk 1: +45.3%

same SICrecent IPO

Apnimed, Inc. APMD

2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%

same SICrecent IPO

Kardigan, Inc. KARD

2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%

same SICrecent IPO

Parabilis Medicines, Inc. PBLS

2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%

same SICrecent IPO

Seaport Therapeutics, Inc. SPTX

2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%

same SICrecent IPO

Recent News

No recent news stored for this issuer.